Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04654000 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04654000 · ClinicalTrials.gov record · last posted 2026-02-12

Rheopheresis as Adjuvant Treatment of Calciphylaxis

Study acronym: RHEO-CAL
StatusRecruiting
PhaseNot applicable
Started2023-03-07
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The investigators propose to set up a prospective randomized controlled trial to control the security and assess the efficacy of adjuvant treatment by rheopheresis in necrotizing-ulcered calciphylaxis in the hemodialysis population.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2020-12-02; most recent amendment 2026-02-09. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2026-02-09
Status change Enrolling by Invitation→Recruitingv2
2023-02-14
Status change Not Yet Recruiting→Enrolling by Invitationv1
Trial Details
NCT Number NCT04654000
Lead Sponsor University Hospital, Lille
Collaborators: Direction Générale de l'Offre de Soins
Conditions Metabolic Disorder, End Stage Renal Disease, Rare Diseases
Enrollment 138 participants
Start Date 2023-03-07
Primary Completion 2027-04 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-12